Susquehanna International Group
TFFP

Susquehanna International Group’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Susquehanna International Group’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-400
Closed -$41K – 13971
2022
Q3 		$41K Sell
400
-636
-61% -$86K ﹤0.01% 12321
2022
Q2 		$146K Sell
1,036
-840
-45% -$117K ﹤0.01% 11061
2022
Q1 		$296K Sell
1,876
-1,516
-45% -$245K ﹤0.01% 10311
2021
Q4 		$752K Sell
3,392
-8
-0.2% -$1.55K ﹤0.01% 8057
2021
Q3 		$656K Sell
3,400
-1,368
-29% -$290K ﹤0.01% 8689
2021
Q2 		$1.15M Buy
4,768
+1,596
+50% +$438K ﹤0.01% 7389
2021
Q1 		$1.08M Sell
3,172
-1,008
-24% -$410K ﹤0.01% 7542
2020
Q4 		$1.5M Buy
4,180
+2,092
+100% +$805K ﹤0.01% 5749
2020
Q3 		$964K Buy
+2,088
New +$589K ﹤0.01% 6199

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's TFFP Position: Q4 2023 in Review

Susquehanna International Group sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 660 shares — an estimated $5.78K sold.

Susquehanna International Group first reported a position in TFFP in Q3 2020 and held it in 12 quarters. The position peaked at $3.39M in Q4 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

  • Susquehanna International Group reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 660 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $5.78K.
  • Susquehanna International Group first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Susquehanna International Group's TFF Pharmaceuticals, Inc. Common Stock position peaked at $3.39M in Q4 2021.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.